Non-invasive biomarkers and scoring systems show strong capability in differentiating chronic liver disease from cirrhosis, ...

The international study led by a Virginia Commonwealth University researcher found the medication semaglutide, commonly known ...

Global research into the gut microbiome has exploded over the past decade, with most of the spotlight shining on the complex, ...

Discover 7 powerful signs your liver is healing after you stop drinking alcohol, from improved energy to better digestion and ...

From 2006 to 2019, age-adjusted mortality for liver disease in the US increased by 14% overall and by 24% during COVID, from 2019 through 2021.

Semaglutide injections reversed some cases of MASH liver disease in clinical trials, reducing inflammation in 62.9% of ...

Early menopause before age 50 significantly increases the risk of fatty liver disease and metabolic disorders, according to ...

AMSTERDAM — As artificial intelligence (AI) becomes increasingly embedded within healthcare, including liver care, it will be ...

Fatty liver disease, also called metabolic dysfunction-associated steatohepatitis (MASH), is a condition where fat ...

Nearly twice as many people taking semaglutide stopped their fatty liver disease without further scarring of the organ, ...

California biotech NGM Bio is slimming down as the company pivots focus, shedding around 75% of staff, pausing development of ...

To test their new drug, the researchers conducted experiments on mice that were fed a high-fat diet, which typically leads to ...